BP
CELG

Ballentine Partners’s Celgene Corp CELG Stock Holding History

Ballentine Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,957
Closed -$393K – 424
2019
Q3 		$393K Buy
3,957
+194
+5% +$18.4K 0.02% 242
2019
Q2 		$348K Buy
3,763
+533
+17% +$50.6K 0.02% 267
2019
Q1 		$305K Buy
+3,230
New +$282K 0.02% 242
2018
Q4 		– Sell
-3,148
Closed -$281K – 403
2018
Q3 		$281K Buy
3,148
+456
+17% +$40.3K 0.01% 272
2018
Q2 		$214K Sell
2,692
-1,574
-37% -$131K 0.01% 310
2018
Q1 		$380K Sell
4,266
-689
-14% -$66.1K 0.02% 225
2017
Q4 		$518K Sell
4,955
-1,924
-28% -$217K 0.03% 185
2017
Q3 		$1M Sell
6,879
-234
-3% -$31.9K 0.06% 121
2017
Q2 		$967K Buy
7,113
+2,245
+46% +$275K 0.07% 131
2017
Q1 		$606K Sell
4,868
-258
-5% -$30.9K 0.04% 107
2016
Q4 		$564K Buy
5,126
+343
+7% +$38.2K 0.04% 97
2016
Q3 		$500K Sell
4,783
-109
-2% -$11.8K 0.04% 98
2016
Q2 		$483K Sell
4,892
-135
-3% -$14K 0.04% 113
2016
Q1 		$504K Buy
5,027
+2,318
+86% +$239K 0.04% 107
2015
Q4 		$324K Buy
2,709
+15
+0.6% +$1.74K 0.03% 134
2015
Q3 		$292K Buy
2,694
+522
+24% +$64.8K 0.03% 135
2015
Q2 		$251K Buy
2,172
+27
+1% +$3.09K 0.02% 138
2015
Q1 		$247K Sell
2,145
-2
-0.1% -$239 0.02% 137
2014
Q4 		$240K Buy
+2,147
New +$226K 0.03% 140

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Ballentine Partners's CELG Position: Q4 2019 in Review

Ballentine Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,957 shares — an estimated $393K sold.

Ballentine Partners first reported a position in CELG in Q4 2014 and held it in 19 quarters. The position peaked at $1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ballentine Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ballentine Partners sold 3,957 Celgene Corp shares in Q4 2019, an estimated $393K.
  • Ballentine Partners first reported a position in Celgene Corp in Q4 2014 and held it in 19 quarters.
  • Ballentine Partners's Celgene Corp position peaked at $1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ballentine Partners's 13F filing for Q4 2019, filed 22 Jan 2020.